{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:41:09Z","timestamp":1772660469301,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.numecd.2020.05.013","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T04:18:45Z","timestamp":1590725925000},"page":"1227-1235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-5493","authenticated-orcid":false,"given":"Francesco P.","family":"Cappuccio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Siani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2020.05.013_bib2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.numecd.2020.05.013_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of Coronaviruses on the cardiovascular system. A review","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.numecd.2020.05.013_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","author":"Richardson","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2020.05.013_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2020.05.013_bib7","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2020.05.013_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.numecd.2020.05.013_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of Renin-Angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for Coronavirus Disease 2019 (COVID-19) infection in Wuhan, China","author":"Li","year":"2020","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.numecd.2020.05.013_bib10","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of covid-19","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15312","article-title":"RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study","author":"Conversano","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2020.05.013_bib12","article-title":"Cardiovascular disease, drug therapy, and mortality in Covid-19","author":"Mehra","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for Coronavirus Disease 2019 (COVID-19)","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2020.05.013_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin-system inhibitors improve the clinical outcome of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.numecd.2020.05.013_bib15","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-Angiotensin-Aldosterone system inhibitors and risk of Covid-19.","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardian injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.numecd.2020.05.013_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.numecd.2020.05.013_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.numecd.2020.05.013_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2020.05.013_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with covid-19 and pre-existing type 2 diabetes","author":"Zhu","year":"2020","journal-title":"Cell Metabol"},{"key":"10.1016\/j.numecd.2020.05.013_bib22","doi-asserted-by":"crossref","DOI":"10.20452\/pamw.15272","article-title":"Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis","author":"Lippi","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia. A systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"22","key":"10.1016\/j.numecd.2020.05.013_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009683","article-title":"Inpatient and outpatient infection as a trigger of cardiovascular disease: the ARIC study","volume":"7","author":"Cowan","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"suppl 7","key":"10.1016\/j.numecd.2020.05.013_bib25","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1086\/432001","article-title":"Underlying disorders and their impact on the host response to infection","volume":"41","author":"Dhainaut","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.numecd.2020.05.013_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2020.04.001","article-title":"A close-up on COVID-19 and cardiovascular diseases","author":"Li","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.numecd.2020.05.013_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2020.05.013_bib29","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-Angiotensin System blockers and the COVID-19 pandemic. At present there is no\u00a0evidence to abandon renin-angiotensin system blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2020.05.013_bib31","first-page":"e1","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"4","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.numecd.2020.05.013_bib32","doi-asserted-by":"crossref","first-page":"m1313","DOI":"10.1136\/bmj.m1313","article-title":"Drugs and the renin-angiotensin system in\u00a0covid-19","volume":"369","author":"Aronson","year":"2020","journal-title":"Br Med J"},{"key":"10.1016\/j.numecd.2020.05.013_bib33","article-title":"Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute hospital trust","author":"Bean","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.numecd.2020.05.013_bib34","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2020.05.013_bib35","unstructured":"https:\/\/www.eshonline.org\/spotlights\/esh-statement-covid-19\/ 2020. (Accessed 11 May 2020)."}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320302064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320302064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:12:38Z","timestamp":1760544758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475320302064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0939475320302064"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2020.05.013","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2020.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}